AFAIK RAC isn't going to test bisantrene on prostate cancer.
If you mean the risk that bisantrene might worsen the disease in say breast cancer, that's extremely low because of the historical trials and the preclinicals.
- Forums
- ASX - By Stock
- Pillar 1 - FTO (new thread)
AFAIK RAC isn't going to test bisantrene on prostate...
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.47 |
Change
0.010(0.69%) |
Mkt cap ! $245.0M |
Open | High | Low | Value | Volume |
$1.46 | $1.50 | $1.43 | $48.84K | 33.47K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 680 | $1.47 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.49 | 340 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 680 | 1.470 |
1 | 2294 | 1.460 |
1 | 2785 | 1.455 |
2 | 4399 | 1.450 |
2 | 5700 | 1.430 |
Price($) | Vol. | No. |
---|---|---|
1.490 | 340 | 1 |
1.495 | 6891 | 1 |
1.500 | 7377 | 3 |
1.510 | 2408 | 1 |
1.540 | 10000 | 1 |
Last trade - 13.37pm 24/05/2024 (20 minute delay) ? |
|
|||||
Last
$1.46 |
  |
Change
0.010 ( 0.23 %) |
|||
Open | High | Low | Volume | ||
$1.44 | $1.49 | $1.43 | 9034 | ||
Last updated 13.08pm 24/05/2024 ? |
Featured News
RAC (ASX) Chart |